Redpoint Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Redpoint Investment Management's GILD Position: Q3 2022 in Review
Redpoint Investment Management reduced its Gilead Sciences (GILD) stake by 4.9% in Q3 2022, selling an estimated $98.1K and leaving 30,076 shares worth $1.85M. The position accounts for 0.27% of the portfolio, ranked #87.
Redpoint Investment Management first reported a position in GILD in Q4 2017 and has held it in 20 quarters since. The position peaked at $8.72M in Q1 2018. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.
- Redpoint Investment Management held 30,076 shares of Gilead Sciences worth $1.85M as of Q3 2022.
- Redpoint Investment Management sold 1,556 Gilead Sciences shares in Q3 2022, an estimated $98.1K.
- Gilead Sciences made up 0.27% of Redpoint Investment Management's portfolio in Q3 2022, its #87 holding.
- Redpoint Investment Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 20 quarters since.
- Redpoint Investment Management's Gilead Sciences position peaked at $8.72M in Q1 2018.
- 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.
Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.